JANX FY 2025 Earnings — Janux Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

JANXJanux Therapeutics, Inc.

$852M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M-5.6% YoY

Gross Profit

$8M79.7% margin

Operating Income

-$158M-1576.7% margin

Net Income

-$114M-1136.3% margin

EPS (Diluted)

$-1.83

Cash Flow

Operating Cash Flow

-$82M

Free Cash Flow

-$83M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$45M

Stockholders' Equity

$957M

Cash & Equivalents

$52M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$11M	-5.6%
Gross Profit	$8M	$9M	-6.5%
Operating Income	-$158M	-$99M	-59.5%
Net Income	-$114M	-$69M	-64.7%